Chloramphenicol Promotes Abnormal Cell Differentiation and Inhibits Apoptosis: A Potential Link to Leukemia

Zengrong Yuan,Yufang Shi
IF: 11.2
2004-01-01
Cancer Research
Abstract:Proc Amer Assoc Cancer Res, Volume 45, 2004 1537 Chloramphenicol is a broad-spectrum antibiotic and has been used to effectively control various infectious diseases worldwide. However, the development of leukemia following chloramphenicol administration is a serious side-effect in clinical medicine. The mechanisms underlining this leukemogenesis process have not been defined. In this study, we investigated the effect of chloramphenicol on activation of both human and mouse T cells. By stimulated mouse splenocytes and human peripheral mononuclearcytes with staphylococcal enterotoxin B in the presence of chloramphenicol, we found that chloramphenicol could induce these cells to undergo very abnormal differentiation characterized by very large size and multiploid nuclei. These cells express early T cell marker CD7, a phenotypic change may represent a differentiation process towards leukemogenesis. Interestingly, chloramphenicol also significantly inhibits activation-induced cell death observed in mouse lymphoblastic cells and several other human and mouse T cell lines. Blocking Fas ligand expression on surface of activated T cells is molecular mechanism for chloramphenicol inhibition in cell apoptosis. Since apoptosis plays a critical role for cellular homeostasis during tumorigenesis and immune response, our findings may potentially demonstrate a leukemogenesis mechanism associated with the application of chloramphenicol in clinic.
What problem does this paper attempt to address?